News

The Medtronic platforms were shown in clinical trials to reduce repeat revascularization, cardiac death, and stent thrombosis in 1 year following procedure.

The loteprednol etabonate ophthalmic gel 0.38% was proven efficacious and safe in a pair of double-masked trials, and will reach the market by April 2019.

New research based on 8 flu seasons’ worth of data supports the early use of oseltamivir, particularly in cases of A(H3N2) influenza.

The investigators also examined patients who had 3 or more injections in the year prior to their cardiac event.

Anxiety and depression each contribute to impaired cognition in patients with MS and other immune-mediated disorders, a new study shows.

Direct-acting antiviral treatment of HCV prior to liver transplant does not increase pre-transplant liver cancer progression or post-transplant recurrence.

As people age, their B cells become less adaptive, leaving them more susceptible to the flu.

A new CMS-based study reports that annual healthcare spending growth should exceed an average of 5%, and that spending will shift from private to Medicare.

Behavioral model predicts when MS patients decline treatment for delayed or insufficient benefit, and the probability and severity of side effects.

The intranasal epinephrine spray is being developed for use with Intravail, a nasal absorption enhancing technology.

The first prospective, longitudinal study of direct-acting antivirals for HCV finds that treatment reduces risks of all-cause mortality and liver cancer.

Each flu season, the race is on to determine how well the flu vaccine is working. But researchers caution that many of the studies used to calculate effectiveness have potential pitfalls.

FDA trial approval would make this trial the first ever to test a stem cell-based therapy derived from induced pluripotent stem cells for treating any disease.

An investigational non-opioid pain medication, tanezumab demonstrated statistically significant pain reduction at 16 weeks compared to placebo.

The Novo Nordisk drug has been granted approved with supporting evidence from a 270-patient assessment—the largest pre-registration clinical program ever conducted in the hemophilia A field.

A new analysis of an ongoing clinical study offers insights for treating retinal vein occlusion in poor responders to bevacizumab.

William Lennarz, MD, touches on unique aspects of a pediatric ER, including staffing, equipment needs, medication dosing, and working with EMS to improve children's experiences.

Characterizing these pediatric epilepsy readmissions is the first step in reducing readmissions, study authors said.

Asthma risk and lung disease development can occur as easily and as frequently with smoking alternatives as it does with combustible cigarettes.

A new Cleveland Clinic study has programmed EHRs to limit the rate of chest X-rays among patients. How has it helped both their stay and treatment progression rates?

Investigators have found that mice with ALS given the novel treatment showed significant improvements in their cognitive and motor performance.

A new cohort from the Cleveland Clinic shows that the index could allow ICU clinicians to know whether a patient needs prone positioning or ECMO.

The known medium of communication between the immune system and central nervous system, metabolites could believably play a role in the multiple sclerosis disease course.

William Lennarz, MD, shares about the positive aspects of providing pediatric emergency care in New Orleans, as well as the challenge of preparing for the next big hurricane.

Both sex- and age-specific therapies could come to clinical asthma field in upcoming years.

Ketamine looks promising as a potential therapy for treatment-resistant depression. The problem is that more research is needed to understand it.

William Lennarz, MD, describes the efforts among those in the specialty to reduce pain and anxiety during children's visits to the emergency room.

The t:Slim X2 insulin pump is both compatible with outside therapy systems, and capable of delivering insulin on its own.